Tuberculosis and diabetes: Current state and future perspectives

Tropical Medicine and International Health

Volumn 21, Issue 6, 2016, Pages 694-702

  Pizzol, Damiano ^a   Di Gennaro, Francesco ^b   Chhaganlal, Kajal D ^c   Fabrizio, Claudia ^b   Monno, Laura ^b   Putoto, Giovanni ^d   Saracino, Annalisa ^b  

^a Research Section   (Mozambique)

^b UNIVERSITY OF BARI   (Italy)

^c Ilha de Moc mbique   (Mozambique)

^d Research Section   (Italy)

Author keywords

Africa; Developing countries; Diabetes; Global health; Non communicable diseases; Tuberculosis

Indexed keywords

INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; RIFAMPICIN;

DEVELOPING WORLD; DIABETES; DISEASE INCIDENCE; DISEASE TREATMENT; EPIDEMIOLOGY; FUTURE PROSPECT; GLOBAL PERSPECTIVE; HISTOPATHOLOGY; PHYSIOLOGY; TUBERCULOSIS;

CLINICAL FEATURE; DEVELOPING COUNTRY; DIABETES CONTROL; DIABETES MELLITUS; DIET THERAPY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GLYCEMIC CONTROL; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; LIFESTYLE MODIFICATION; MYCOBACTERIUM TUBERCULOSIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PUBLIC HEALTH PROBLEM; REVIEW; RISK FACTOR; SOCIAL DETERMINANTS OF HEALTH; SPUTUM SMEAR; TUBERCULOSIS; UNDERWEIGHT; COMPLICATION; DIABETIC COMPLICATION;

AFRICA;

DEVELOPING COUNTRIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; TUBERCULOSIS;

EID: 84973176491     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12704     Document Type: Review

References (117)

1. WHO. Global Tuberculosis Report 2015. World Health Organization (WHO): Geneva, 2015.
2. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2015: 38(Suppl. 1): S8-S16.
3. Van Crevel R, Dockrell HM, TANDEM Consortium. TANDEM: understanding diabetes and tuberculosis. Lancet Diabetes Endocrinol 2014: 2: 270-272.
4. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009: 9: 737-746.
5. Restrepo BI. Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis 2007: 45: 436-438.
6. Sen T, Joshi SR, Udwadia ZF. Tuberculosis and diabetes mellitus: merging epidemics. J Assoc Physicians India 2009: 57: 399-404.
7. Faurholt-Jepsen D, Range N, PrayGod G et al. Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PLoS One 2011: 6: e24215.
8. Mi F, Tan S, Liang L et al. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China. Trop Med Int Health 2013: 18: 1379-1385.
9. Alisjahbana B, Sahiratmadja E, Nelwan FJ et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007: 45: 428-435.
10. Faurholt-Jepsen D, Range N, PrayGod G et al. Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania. Trop Med Int Health 2013: 7: 822-829.
11. Baker MA, Harries AD, Jeon CY et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011: 9: 81.
12. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008: 5: e152.
13. Fisher-Hoch SP, Mathews CE, McCormick JB. Obesity, diabetes and pneumonia: the menacing interface of non-communicable and infectious diseases. Trop Med Int Health 2013: 18: 1510-1519.
14. Lönnroth K, Castro KG, Chakaya JM et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010: 375: 1814-1829.
15. WHO. Systematic Screening for Active Tuberculosis: Principles and Recommendations. World Health Organization (WHO): Geneva, 2013, 133 p.
16. Dye C. Tuberculosis 2000-2010: control, but not elimination. Int J Tuberc Lung Dis 2000: 4: S146-S152.
17. Dalal S, Beunza JJ, Wolmink J et al. Non-communicable disease in sub-Saharan Africa: what we know. Int J Epidemiol 2011: 40: 885-901.
18. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004: 27: 1047-1053.
19. WHO. Global Status Report on Non-Communicable Disease 2014. World Health Organization (WHO): Geneva, 2014, 2015.
20. Echouffo-Tcheugui JB, Dagogo-Jack S. Preventing diabetes mellitus in developing countries. Nat Rev Endocrinol 2012: 8: 557-562.
21. Motala AA, Esterhuizen T, Gouws E, Pirie FJ, Omar MAK. Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors. Diabetes Care 2008: 31: 1783-1788.
22. Levitt NS. Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 2008: 94: 376-382.
23. Baker MA, Lin HH, Chang HY, Murray MB. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis 2012: 54: 818-825.
24. Shen TC, Lin CL, Wei CC et al. Increased risk of tuberculosis in patients with type 1 diabetes: results from a population based cohort study in Taiwan. Medicine Baltimore 2014: 93: e96.
25. Hall V, Thomsen RW, Henrikesen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health 2011: 11: 564.
26. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet 2010: 375: 2254-2266.
27. Young F, Critchley JA, Johnstone LK, Unwin NC. A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa. TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health 2009: 5: 9.
28. Leung CC, Lam TH, Chan WM et al. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 2008: 167: 1486-1494.
29. Stevenson CR, Forouhi NG, Roglic G et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007: 7: 234.
30. Baghaei P, Marjani M, Javanmard P, Tabarsi P, Masjedi MR. Diabetes mellitus and tuberculosis facts and controversies. J Diabetes Metab Disord 2013: 12: 58.
31. Delgado-Sánchez G, García-García L, Castellanos-Joya M et al. Association of pulmonary tuberculosis and diabetes in Mexico: analysis of the national tuberculosis registry 2000-2012. PLoS One 2015: 10: e0129312.
32. Dobler C, Flack J, Marks G. Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open 2012: 2: e000666.
33. Lawn SD, Zumla AI. Tuberculosis. Lancet 2011: 378: 57-72.
34. Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med 2013: 368: 745-355.
35. Joshi N, Caputo GM, Weitekamp MR, Karchmer A. Infections in patients with diabetes mellitus. N Engl J Med 1999: 341: 1906-1912.
36. Muller L, Gorter K, Hak E et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005: 41: 281-288.
37. Davies PD. Risk factors for tuberculosis. Mon Arch Chest Dis 2005: 63: 37-46.
38. Kumar NP, Banurenkha VV, Nair D et al. Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis. PLoS One 2014: 9: e112108.
39. Kumar NP, Sridhar R, Nair D, Banurekha VV, Nutman TB, Babu S. Type 2 diabetes mellitus is associated with altered CD8+ T and natural killer cell function in pulmonary tuberculosis. Immunology 2015: 144: 677-686.
40. Martinez N, Kornefeld H. Diabetes and immunity to tuberculosis. Eur J Immunol 2014: 44: 617-626.
41. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999: 26: 259-265.
42. Tack CJ, Stienstra R, Joosten LA, Netea MG. Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol Rev 2012: 249: 239-252.
43. Jick S, Lieberman E, Rahaman M, Choi HK. Glucocorticoid use, other associated factors, and risk of tuberculosis. Arthritis Rheum 2006: 55: 19-26.
44. Kibirige D. Endocrine dysfunction among adult patients with tuberculosis: an African experience. Indian J Endocrinol Metab 2014: 18: 288-294.
45. Mollentze WF, Pansegrouw DF, Steyn AF. Diabetes mellitus, pulmonary tuberculosis and chronic calcific pancreatitis revisited. S Afr Med J 1990: 78: 235.
46. Voloshyn IaM. The pulmonary resection for tuberculosis in patients with severe diabetes mellitus. Klin Khir 2000: 5: 30-31.
47. Sullivan T, Amor YB. The co-management of tuberculosis and diabetes: challenges and opportunities in the developing word. PLoS Med 2012: 9: e1001269.
48. Hong JY, Kim SY, Chung KS et al. Association between vitamin D deficiency and tuberculosis in a Korean population. Int J Tuberc Lung Dis 2014: 18: 73-78.
49. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Daibetologia 2005: 48: 1247-1257.
50. Zhan Y, Jiang L. Status of vitamin D, antimicrobial peptide cathelicidin and T helper associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis. Exp Ther Med 2015: 9: 11-16.
51. Thye T, Owusu-Dabo E, Vannberg FO et al. Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat Genet 2012: 44: 257-259.
52. Ottenhoff TH, Verreck FA, Hoeve MA, van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis 2005: 85: 53-64.
53. Qu H-Q. Host susceptibility to tuberculosis: insights from a longitudinal study of gene expression in diabetes. Int J Tuberc Lung Dis 2012: 16: 370-372.
54. Thye T. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet 2010: 42: 739-741.
55. Png E, Alisjahbana B, Sahiratmadja E et al. A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians. BMC Med Genet 2012: 13: 5.
56. Iwai H, Funatogawa K, Matsumura K et al. MicroRNA-155 knockout mice are susceptible to Mycobacterium tuberculosis infection. Tuberculosis 2015: 95: 246-250.
57. Kim JK, Yuk JM, Kim SY et al. MicroRNA-125a inhibits autophagy activation and antimicrobial responses during mycobacterial infection. J Immunol 2015: 194: 5355-5365.
58. Xu Z, Zhou A, Ni J et al. Differential expression of miRNAs and their relation to active tuberculosis. Tuberculosis 2015: 95: 395-403.
59. Zheng L, Leung E, Lee N et al. Differential microRNA expression in human macrophages with mycobacterium tuberculosis infection of Beijing/W and non-Beijing/W strain types. PLoS One 2015: 10: e0126018.
60. Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulmonary Med 2013: Article ID 828939: 11 pages http://dx.doi.org/10.1155/2013/828939.
61. Agaya J, Nnadi CD, Odhiambo J et al. Tuberculosis and latent tuberculosis infection among healthcare workers in Kisumu, Kenya. Trop Med Int Health 2015: 20: 1797-1804.
62. Raviglione M, Marais B, Floyd K et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 2012: 379: 1902-1913.
63. Rasanathan K, Sivasankara Kurup A, Jaramillo F, Lonroth K. The social determinants of health: key to global tuberculosis control. Int J Tuber Lung Dis 2011: 15: S30-S36.
64. Lönroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009: 68: 2240-2246.
65. Horsburgh CR, Rubin EJ. Latent tuberculosis infection in the United States. N Eng J Med 2011: 364: 1441-1448.
66. Marais BJ, Lönnroth K, Lawn SD et al. Tuberculosis comorbidity with communicable and non-communicable disease: integrating health services and control efforts. Lancet Infect Dis 2013: 13: 436-448.
67. Gupta S, Shenoy VP, Mukhopadhyay C, Bairy I, Muralidharan S. Role of risk factors and socio-economic status in pulmonary tuberculosis: a search for the root cause in patients in a tertiary care hospital, South India. Trop Med Int Health 2011: 16: 74-78.
68. Goldhaber-Fiebert JD, Jeon CY, Cohen T, Murray MB. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. Int J Epidemiol 2011: 40: 417-428.
69. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. Am J Public Health 2011: 101: 654-662.
70. Kirenga BJ, Ssengooba W, Muwonge C et al. Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control. BMC Public Health 2015: 15: 13.
71. Wen C-P, Chan T-C, Chan H-T, Tsai M-K, Cheng T-Y, Tsai S-P. The reduction of tuberculosis risks by smoking cessation. BMC Infect Dis 2010: 10: 156.
72. Chiang CY, Slama K, Enarson DA. Associations between tobacco and tuberculosis. Int J Tuberc Lung Dis 2007: 11: 258-262.
73. Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis-a systematic review. BMC Public Health 2008: 8: 289.
74. De Colombani P, Hovhannesyan A, Wolfheze Working Group on Social Determinants of TB and Drug Resistant TB. Social determinants and risk factors for tuberculosis in national surveillance systems in Europe. Public Health Action 2015: 5: 194-201.
75. Blumberg HM, Burman WJ, Chaisson RE et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Resp Crit Care Med 2003: 167: 603-662.
76. Dye C, Bourdin Trunz B, Lonnroth K, Roglic G, Williams BG. Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS One 2011: 6: e21161.
77. Niazi AK, Kalra S. Diabetes and tuberculosis: a review of the role of optimal glycemic control. J Diabetes Metab Disord 2012: 11: 28.
78. Heo EY, Choi N-K, Yang BR, Koo BK, Hwang S-S, Lee C-H, Kang YA. Tuberculosis is frequently diagnosed within 12 months of diabetes mellitus. Int J Tuberc Lung Dis 2015: 19: 1098-101.
79. Badawi A, Sayegh S, Sallam M et al. The global relationship between the prevalence of diabetes mellitus and incidence of tuberculosis: 2000-2012. Glob J Health Sci 2015: 7: 183-191.
80. Liu L, Yin X, Morrissey S. Global variability in diabetes mellitus and its association with body weight and primary healthcare support in 49 low- and middle-income developing countries. Diabet Med 2012: 29: 995-1002.
81. Sairenchi T, Iso H, Irie F, Fukasawa N, Ota H, Muto T. Underweight as a predictor of diabetes in older adults: a large cohort study. Diabetes Care 2008: 31: 583-584.
82. Viswanathan V. et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One 2012: 7: e41367.
83. Faurholt-Jepsen D, Range N, Praygod G et al. The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania. BMC Infect Dis 2012: 12: 165.
84. Ogbera AO, Kapur A, Abdur-Razzaq H et al. Clinical profile of diabetes mellitus in tuberculosis. BMJ Open Diabetes Res Care 2015: 3: e000112.
85. Faurholt-Jepsen D, Range N, PrayGod G et al. The role of diabetes on the clinical manifestations of pulmonary tuberculosis. Trop Med Int Health 2012: 17: 877-883.
86. Skowronski M, Zozulinska-Ziolkiewicz D, Barinow-Wojewodzki A. Tuberculosis and diabetes mellitus: an underappreciated association. Arch Med Sci 2014: 10: 1019-1027.
87. Perez-Guzman C, Torres-Cruz A, Villareal-Velarde H, Vargas MH. Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med 2000: 162: 1738-1740.
88. Alavi SM, Khoshko MM, Salmanzadeh S, Eghtesad M. Comparison of Epidemiological, Clinical, Laboratory and Radiological Features of Hospitalized Diabetic and Non-Diabetic Patients with pulmonary tuberculosis at Razi Hospital in Ahavaz. Jundishapur J Microbial 2014: 7: e12247.
89. Harries AD, Billo N, Kapur A. Links between diabetes mellitus and tuberculosis: should we integrate screening and care? Trans R Soc Trop Med Hyg 2009: 103: 1-2.
90. Jeon CY, Harries AD, Baker MA et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health 2010: 15: 1300-1314.
91. WHO Guidelines Approved by the Guidelines Review Committee. Xpert MTB/RIF Implementation Manual: Technical and Operational 'How-To'; Practical Considerations. World Health Organization: Geneva, 2014.
92. Walusimbi S, Bwanga F, De Costa A, Halle M, Joloba M, Hoffner S. Meta-analysis to compare the accuracy of GeneXpert, MODS and WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis. BMC Infect Dis 2013: 13: 507.
93. Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol 2011: 49: 4138-4141.
94. Held M, Laubscher M, Zar HJ, Dunn RN. GeneXpert polymerase chain reaction for spinal tuberculosis: an accurate and rapid diagnostic test. Bone Joint J 2014: 96: 1366-1369.
95. Boillat-Blanco N, Ramaiya KL, Mganga M et al. Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms. J Infect Dis 2016: 213: 1163-1172.
96. WHO/IDF. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF Consultation World Health Organization Geneva 2006-recommendation 5), 2006.
97. Umut S, Tosun GA, Yildirim N. Radiographic location of pulmonary tuberculosis in diabetic patients. Chest 1994: 106: 326.
98. Weaver R. Unusual radiographic presentation of pulmonary tuberculosis in diabetic patients. Am Rev Respir Dis 1997: 109: 162-163.
99. Martínez-Aguilar G, Serrano CJ, Castañeda-Delgado JE et al. Associated risk factors for latent tuberculosis infection in subjects with diabetes. Arch Med Res 2015: 46: 221-227.
100. WHO. Collaborative Framework for Care and Control of Tuberculosis and Diabetes. World Health Organization: Geneva, 2011.
101. Restrepo BI, Pino PA, Zarate I, Mora-Guzman F. Dipstick urinalysis for diabetes screening in TB patients. Int Health 2013: 5: 157-159.
102. Chiang CY, Lee JJ, Chien ST et al. Glycemic control and radiographic manifestations of tuberculosis in diabetic patients. PLoS One 2014; 9: e93397.
103. Riza AL, Pearson F, Ugarte-Gil C et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol 2014: 2: 740-753.
104. Harries AD, Kumar AM, Satyanarayana S et al. Diabetes mellitus and tuberculosis: programmatic management issues. Int J Tuberc Lung Dis 2015: 19: 879-886.
105. Wang J-Y, Lee M-C, Shu C-C et al. Optimal duration of anti-TB treatment in patients with diabetes nine or six months? Chest 2015: 147: 520-528.
106. Singhal A, Jie L, Kumar P et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med 2014: 6: 263ra159.
107. Kapur A, Harries AD. The double burden of diabetes and tuberculosis - public health implications. Diabetes Res Clin Pract 2013: 101: 10-19.
108. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJ, van Crevel R. Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health 2010: 15: 1289-1299.
109. Harries AD, Kumar AM, Satyanarayana S et al. Addressing diabetes mellitus as part of the strategy for ending TB. Trans R Soc Trop Med Hyg 2016: 110: 173-179.
110. Stevenson CR, Critchley JA, Forouhi NG et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 2007: 3: 228-245.
111. IDF (International Diabetes Federation). Diabetes Atlas. IDF (International Diabetes Federation): (6th edn), 2015.
112. Lönnroth K, Roglic G, Harries AD. Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. Lancet Diabetes Endocrinol 2014: 2: 730-739.
113. Mayosi BM et al. Health in South Africa: changes and challenges since 2009. Lancet 2012: 380: 2029-2043.
114. Odone A, Houben RM, White RG, Lonnroth K. The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol 2014: 2: 754-764.
115. Harries AD, Murray MB, Jeon CY et al. Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis. Trop Med Int Health 2010: 15: 659-663.
116. Jaffar S, Amberbir A, Kayuni N, Musicha C, Nyirenda M. Viewpoint: scaling up testing services for non-communicable diseases in Africa: priorities for implementation research. Trop Med Int Health 2013: 18: 1353-1356.
117. Kapur A, Harries AD, Lonnroth K, Wilson P, Sulistyowati LS. Diabetes and tuberculosis co-epidemic: the Bali Declaration. Lancet Diabetes Endocrinol 2016: 4: 8-10.